Research News

A new protein as a target for cancer treatment

Any disruption in RNA processing by RNA binding proteins (RBPs) may lead to cancers. This research article published by Natures Communications and helmed by Associate Professor Polly Chen provides insights into the role of a cancer associated protein, DAP3, in cancer development. Findings in this research article suggests that targeting or blocking the protein DAP3 may hold great promise for cancer treatment.

Read more: https://www.nature.com/articles/s41467-022-29400-7#article-info

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

ZBTB48: A New On-Switch for the Immune Response

CIITA is the master regulator of MHC class-II immune genes that are important for defense mechanism against infections and cancer …

Read More →
Research News

Magnetic Field Therapy Improves Breast Cancer Treatment with Fewer Side Effects

Chemotherapy, although the first line of defense in cancer treatment, is indiscriminate and is damaging to the entire body, which, …

Read More →
Research News

Extracellular Vesicles: Key Players in Tumour Microenvironment and Drug Resistance

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the …

Read More →